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Walleye dermal sarcoma virus (WDSV) is a complex retrovirus associated with dermal sarcomas of walleye that develop
and regress on a seasonal basis. WDSV contains, in addition to gag, pol, and env, three open reading frames (ORFs)
designated ORF A, ORF B, and ORF C. The polymerase chain reaction technique was used to amplify and clone cDNAs
representing subgenomic viral mRNAs isolated from developing (fall) and regressing (spring) tumors. Nine different singly
or multiply spliced viral transcripts were identified and all were found to utilize a common 5* leader sequence. This leader
sequence is spliced to the pol/env junction or downstream of env to generate singly spliced transcripts. Multiply spliced
transcripts contain the 5* leader, the pol/env junction, and sequences derived from the 3* end of the genome. One multiply
spliced transcript was isolated with the potential to encode the full-length ORF A protein. In addition, WDSV produced
mRNAs that utilize alternative splice acceptor sites which would allow synthesis of five variant forms of the ORF A protein.
In contrast, the ORF B protein is postulated to arise from a singly spliced transcript with the potential to encode the entire
open reading frame. Spliced subgenomic transcripts representing ORF C mRNAs were not identified, suggesting that ORF
C may be encoded from the full-length viral genomic transcript. We estimate that at least a 100-fold lower amount of the
accessory/regulatory subgenomic transcripts exists in developing vs regressing tumors. These results demonstrate that
WDSV undergoes an elaborate pattern of mRNA splicing similar to that of other complex retroviruses. q 1997 Academic Press
INTRODUCTION were unable to transmit disease (Bowser et al., 1996).
There appears to be quantitative and qualitative differ-
Dermal sarcoma of walleye (Stizostedion vitreum) is a ences in both the amount of viral DNA and the extent of
benign cutaneous neoplasm that arises multicentrically virus expression in developing and regressing tumors.
from the superficial surface of the scales and can affect Developing tumors contain £1 copy/cell of viral DNA
up to 27% of walleyes in North American lakes (Bowser whereas regressing tumors have 10–50 copies of viral
et al., 1988; Walker, 1969; Yamamoto et al., 1976, 1985). DNA, most of which is unintegrated viral DNA (Bowser
There is a seasonal prevalence of this disease; tumors et al., 1996, Martineau et al., 1991, 1992). A substantial
develop during the fall, regress in the spring, and are amount of full-length viral RNA is present in the re-
rarely seen in the summer (Bowser et al., 1988). A natu- gressing tumor inocula whereas no viral genomic RNA
rally occurring exogenous retrovirus, walleye dermal sar- was detected in the inocula from developing tumors.
coma virus (WDSV), is associated with these lesions Northern blot analysis of total RNA isolated from re-
(Bowser et al., 1988; Martineau et al., 1991, 1992). WDSV gressing tumors identified full-length viral RNA and sev-
was molecularly cloned from tumor tissue and found to eral subgenomic RNAs (12.7, 7.4, 2.8, and 1.8 kb),
be 12.7 kb in length (Martineau et al., 1992). Sequence whereas in developing tumors only a subgenomic RNA
analysis of a molecular clone identified three open read- of 2.8 kb was detectable (Bowser et al., 1996).
ing frames (ORFs) in addition to gag, pol, and env The study of viral gene expression of WDSV is essen-
(Holzschu et al., 1995). It is likely that these ORFs encode tial to the understanding of the regulatory mechanisms
regulatory/accessory proteins similar to those found with involved in tumorigenesis and it is likely that the proteins
other complex retroviruses (Cullen, 1991, 1992). encoded by the additional ORFs of WDSV are involved
Experimental transmission of walleye dermal sarcoma in the regulation of viral gene expression as well as the
(WDS) has been achieved using walleye fingerlings as development and regression of tumors. In the present
a model system. Cell-free tumor homogenates prepared study the splicing patterns and coding potential of sub-
from regressing tumors (spring) are able to transmit dis- genomic viral mRNAs present in developing and re-
ease in up to 87% of fingerlings by 14 weeks postinocula- gressing tumors were determined.
tion (Bowser et al., 1990, 1996; Martineau et al., 1990). In
MATERIALS AND METHODScontrast, inocula prepared from developing tumors (fall)
RNA isolation, cDNA synthesis, and PCR amplification
Total cellular RNA was isolated from tumor tissue us-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (607) 253-3384. E-mail: jwc3@cornell.edu. ing RNAzolB (Tel-Test, Inc.) and poly(A)/ RNA was se-
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lected using either MicroFast Track (Invitrogen) or a Poly-
ATtract mRNA Isolation System (Promega) according to
the manufacturer’s directions. One microgram of total
RNA or 500 nanograms of poly(A)/ RNA was dissolved
in 11 ml of diethyl pyrocarbonate (DEPC)-treated H2O,
heated to 657 for 10 min, and placed on ice. The samples
were brought to a final volume of 25 ml by the addition
of 5 ml of 51 first-strand synthesis buffer [250 mM Tris –
HCl (pH 8.3 at room temperature), 375 mM KCl, 15 mM
MgCl2], deoxynucleoside triphosphates (dNTP) (Phar-
macia) to 0.5 mM each, antisense oligonucleotide primer
to 0.4 mM, dithiothreitol (DTT) to 4 mM, RNasin (Promega)
to 1.3 U/ml, and Moloney murine leukemia virus reverse
transcriptase (Superscript II, Gibco BRL) to 8 U/ml. The
reaction mixture was incubated at 427 for 1 hr and then
heat inactivated at 707 for 15 min. Five microliters of this
cDNA was amplified by PCR. The PCR mixture consisted
of 20 mM Tris–HCl (pH 8.4), 50 mM KCl, 2 mM MgCl2 ,
a 125 mM concentration of each dNTP, 10 pmol of each
primer, and 2.5 units of Taq DNA polymerase (Gibco BRL)
in a total volume of 100 ml, which was then overlaid with
mineral oil. All samples were denatured at 947 for 5 min
and then each amplification consisted of 30 sec at 947,
30 sec at 567, 3 min at 727 for 35 cycles and 5 min at
727 for 1 cycle.
Oligonucleotides
FIG. 1. Northern blot analysis of a spring and fall tumor. Poly(A)/ RNA
The oligonucleotides used for cDNA synthesis and PCR isolated from a spring (50 ng) and fall (1 mg) tumor was electrophoresed
were as follows: (1) WDSV-18 nucleotide position is based through a 1% formaldehyde agarose gel, blotted onto nitrocellulose,
on the WDSV sequence (Holzschu et al., 1995) 212–232) 5* and hybridized with a WDSV LTR-specific probe. Molecular weight
markers are indicated on the left side of the figure. The 2.8- and 1.8-ATGAAGCAGGAATACCTACCT 3*, (2) R11902 (nucleotide
kb subgenomic transcripts are designated by arrows.position 11,902–11,882) 5*CATCTGGCACCATGCTGATCT
3*, (3) R11654 (nucleotide position 11,654–11,634) 5* CAA-
AGATGTGTTGATTTGTACA 3*, (4) R11552 (nucleotide posi- The blot was crosslinked with UV light and prehybridized
tion 11,552–11,532) 5* CCCGATTCAGCAGCACTA 3*, (5) at 377 in 50% formamide, 1 M NaCl, 0.5% Sarkosyl, 50
R10218 (nucleotide position 10,218–10,199) 5* ACGGCC- mM Pipes (pH 6.8), 100 mg/ml calf thymus DNA, 10 mM
GCAGCAATAACTAC 3*, (6) R6172 (nucleotide position EDTA, and 51 Denhardt’s. Hybridization was carried out
6172–6152) 5* GTCTAGTTTTTGATGGTCTAA 3*. The re- for 36 hr with a 32P-labeled WDSV-specific LTR probe.
striction enzyme sites XbaI and SacII were incorporated The blot was washed in 21 SSC and 0.1% SDS twice for
into the 5* ends of the oligonucleotides to facilitate cloning 15 min at room temperature and then in 21 SSC and
of PCR-amplified products. 0.1% SDS three times for 30 min at 507. The blot was
dried and placed on X-ray film at 0807.Cloning and sequencing of cDNAs
The PCR-amplified products were extracted with phe-
RESULTS AND DISCUSSIONnol–chloroform and precipitated with ethanol. The ampli-
fied products were digested with XbaI and SacII and Previous studies employing total RNA from developing
cloned into pBluescript (SK0) (Stratagene). The DNA se- (fall) and regressing (spring) tumors determined that
quence of the clones was determined by the dideoxy there were differences in the number of transcripts as
chain termination procedure using a Sequenase 2.0 kit well as the amount of expression between these tumors
(U.S. Biochemical) according to manufacturer’s protocols. (Bowser et al., 1996). To more accurately quantitate the
level of viral gene expression, Northern blot analysis was
Northern blot analysis
performed on poly(A)/ mRNA isolated from a spring and
a fall tumor (Fig. 1). Consistent with previous results,Poly(A)/ RNA from a spring tumor (50 ng) and a fall
tumor (1 mg) was electrophoresed through a 1% aga- several viral transcripts (12.7, 7.4, 2.8, and 1.8 kb) were
detected in the spring tumor and only subgenomic tran-rose–formaldehyde gel and transferred to nitrocellulose.
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FIG. 2. (A) Organization of the WDSV genome. (B) Location of the oligonucleotide primers used for RT-PCR. (C) The different exons are represented
by the black lines and are numbered (1 through 5b). The predicted ORFs are designated by the boxes. (D) The location of the splice donors (SD)
and splice acceptors (SA) according to their nucleotide position on the WDSV genome.
scripts of 2.8 and 1.8 kb were found in the fall tumor. in the leader region before the gag gene to one or more
splice acceptors downstream of the pol gene to generateBecause of the abundance of viral RNA in the spring
tumor, 20 times more poly(A)/ mRNA from the fall tumor subgenomic transcripts. We expected that WDSV would
was run on the gel to allow detection of these mRNAs. use the same strategy, and, therefore, cDNA was synthe-
Densitometric scanning of a film exposed for 4 hr re- sized using a primer located in the U3 region of the 3*
vealed that at least 100 times more of the 2.8-kb subgen- LTR (R11902). These cDNAs were then PCR-amplified
omic viral mRNA was present in the spring tumor than with a 5* primer (WDSV-18) located upstream of the pre-
in the fall tumor (data not shown). dicted splice donor, in combination with R11902. PCR-
amplified products were subjected to electrophoresis,To determine the structure of the subgenomic viral
transcripts, cDNAs were amplified from either total or blotted, and hybridized to the WDSV LTR-specific probe
to confirm the presence of WDSV sequence in thepoly(A)/ mRNA isolated from fall and spring dermal sar-
comas. The locations of the primers used for cDNA syn- cDNAs. An example of one of these experiments is
shown in Fig. 3. Although differences in the concentrationthesis and PCR are indicated in Fig. 2B. In all known
retroviruses, splicing occurs from a single splice donor of RT-PCR amplicons are apparent, variation in signal
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for env at position 5974 would be used in both mRNAs
to generate the full-length Env protein. These results con-
firm that the 7.4-kb band detected by Northern blot analy-
sis is the env transcript.
To identify the splice donor(s) and splice acceptor(s)
used to generate mRNAs that would encode ORF A,
cDNAs synthesized with either the R11654 or the R11902
primers were amplified with the WDSV-18/R10218 or
WDSV-18/R11902 primer pairs. Both singly and multiply
spliced cDNAs were cloned and sequenced. Two differ-
ent singly spliced transcripts were identified and found
to splice exon 1 to either exon 4b or exon 4c (Fig. 2C).
The splice acceptors for exon 4b and exon 4c are located
at nucleotide positions 9888 (SA5) and 10005 (SA6), re-
FIG. 3. Southern blot analysis of PCR amplified cDNAs. cDNA was spectively. Four multiply spliced cDNAs were also identi-
synthesized from total RNA isolated from spring and fall tumors and fied. Exon 1 was contained in all of these transcripts and
PCR amplified with the primer pair R11902/WDSV18. PCR products
found to be spliced to exon 2a, exon 2b, or exon 2c.were electrophoresed, blotted onto nitrocellulose, and hybridized with
Each of the four cDNAs contained a different final exon:a WDSV LTR-specific probe. Molecular weight markers are indicated
on the left side of the figure. transcript ORF A-1 spliced exon 2a to exon 3, transcript
ORF A-2 spliced exon 2b to exon 4a, transcript ORF A-3
spliced exon 2b to exon 4b, and transcript ORF A-6
intensity was observed with different RNA preparations. spliced exon 2c to exon 5a (Fig. 2C). The second exons
RT-PCR carried out under these conditions, in which mul- of the multiply spliced transcripts are derived from the
tiple spliced transcripts are being coamplified, are not junction of the pol and env genes. Exon 2a utilizes a
designed to be quantitative. As shown in the following splice acceptor at nucleotide position 5819 (SA2) and a
sections all WDSV subgenomic transcripts were found splice donor at position 5973 (SD2). The splice acceptor
in both spring and fall tumors. at position 5819 (SA2) and splice donor at position 5993
To further characterize these cDNAs and to more pre- (SD3) are used to produce exon 2b. The splice acceptor
cisely determine their splicing pattern on the WDSV ge- at position 5805 (SA1) and the splice donor at position
nome, PCR products were cloned and sequenced. The 5993 (SD3) define exon 2c. Exon 3 is generated by using
majority of clones that were initially sequenced consisted the splice acceptor near the carboxy terminus of env at
of the small, singly spliced orf B transcripts (see below); position 9332 (SA3). The splice acceptors for exons 4a
these results were likely due to size preferences of PCR. In and 4b are located at positions 9867 (SA4) and 10,005
subsequent experiments, cDNAs were synthesized using (SA6), respectively. Exon 5a is produced by using the
R11654 (located just upstream of the polypurine tract) and splice acceptor at nucleotide position 10,290 (SA7). In
PCR amplified with WDSV-18 and 3* primers R11552 (lo- addition to determining the structure of the viral mRNAs,
cated downstream of ORF B), R10218 (located in ORF A),
or R6172 (located near the 5* end of env). All of the cDNAs
utilize the predicted splice donor at nucleotide position TABLE 1
/246 (position based on the start of transcription) to gen-
WDSV Splice Donor and Splice Acceptor Siteserate a common 5* leader sequence (exon 1) (Fig. 2C).
This leader sequence is then spliced to the pol/env junc- Splice site Location Nucleotide sequence
tion or to the 3* end of the genome to generate single
Donorsspliced viral transcripts. Multiply spliced transcripts are
SD1 245 CTG GTGAGTgenerated by splicing of the leader to the pol/env junction
SD2 5,973 AAC ATGGATwhich is subsequently spliced to the 3* end of the genome. SD3 5,993 ATT GCAAGT
Two sets of primer pairs were used to amplify cDNAs Consensus C/AAG GTRAGT
which would encode env. A product of approximately 400 Acceptors
SA1 5,805 CACGACAATTGTCAG Cbp was amplified with the WDSV-18/R6172 primer pair
SA2 5,819 GCATATCATCAACAG Gand a 4.4-kb product was amplified with the WDSV-18/
SA3 9,332 GGTAAAACCACAACT CR10218 primer pair from both fall and spring tumors. SA4 9,867 CCTTTTCTAATCCAG C
Sequencing of the amplified products identified two SA5 9,888 TACCTCTTGTGGCAG C
splice acceptors that were used to generate env coding SA6 10,005 CGTTGCTTCTCACAG A
SA7 10,290 CTCACATCTCTACAG Ctranscripts. The splice acceptor SA1 is located at nucleo-
SA8 10,325 CCCACTTCACTGCAG Ctide position 5805 and SA2 is located at position 5819
Consensus YYYYYYYYYYYNYAG G
(Fig. 2D, Table 1). The initiator AUG previously identified
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another goal of this study was to understand how the ability to encode different forms of the Rev protein have
been isolated from SIV- and HIV-infected cells. Theseopen reading frames contained within these transcripts
would be expressed. In eukaryotes, efficient translation variant proteins are produced when the second coding
exon of rev is alternatively spliced, resulting in aminogenerally initiates at the first AUG in an RNA. Exceptions
to this rule occur when the first AUG is in an unfavorable acid substitutions or deletions (Park et al., 1991, Viglianti
et al., 1990). Transcripts encoding novel chimeric Tat–context resulting in ‘‘leaky scanning’’ and initiation at a
downstream AUG (Kozak, 1989). The initiator AUGs for Rev–Env fusion proteins (Tev or Tnv) have been de-
scribed in HIV-1-infected cells (Benko et al., 1990; Fur-the single spliced ORF A transcripts (ORF A-4 and ORF
A-5) are located at either nucleotide position 9959 or tado et al., 1991; Schwartz et al., 1990).
Previously unidentified ORFs were also found in two10,010 and are positioned 96 and 113 amino acids, re-
spectively, downstream of the predicted AUG for ORF A. of the multiply spliced transcripts. The ORF A-3 transcript
may encode the short ORF present in the second exonAn initiator AUG is present in exons 2a, 2b, and 2c at
position 5880 and may be used in the multiply spliced and the other transcript (ORF A-1) would generate an-
other fusion protein containing 38 amino acids of PolORF A transcripts; however, the Kozak consensus is
weak. Initiation at this AUG in transcript ORF A-1 would and the carboxy 105 amino acids of TM. The original
sequence analysis of WDSV predicted the start of orf Agenerate an ORF that would fuse in frame with the car-
boxy terminus of TM. Transcript ORF A-1 also has the to be at nucleotide position 9674 (Holzschu et al., 1995)
and, in this study, the only transcript capable of encodingpotential to encode a full-length ORF A protein if the AUG
at position 9674 was used for initiation. A small ORF is the predicted full-length protein would be the ORF A-1
transcript. It is possible that initiation occurs at the pre-present in transcript ORF A-3 that would terminate at the
splice junction of exon 2b and 4b. ORF A-3 also has dicted ORF A AUG due to the unfavorable context for
initiation of translation in the second exon (Kozak, 1989).the potential to initiate translation at the AUG located at
position 9959 to produce a truncated ORF A protein. The Whether transcripts containing multiple ORFs serve as
multicistronic mRNAs as in HTLV/BLV tax/rex or HIV rev/ORF in transcript ORF A-2 would initiate at the AUG in
exon 2b and fuse in frame with ORF A. The multiply nef transcripts awaits further investigation (Furtado et al.,
1991; Nagashima et al., 1986; Schwartz et al., 1990).spliced transcript, ORF A-6, would use the AUG at posi-
tion 5880 to generate an ORF that would fuse the carboxy With the exception of one clone, cDNAs from spliced
transcripts with the potential to encode ORF C were notend of pol in frame to the carboxy terminus of ORF A.
Two types of cDNAs that would likely encode ORF B isolated from developing or regressing tumors. Sequence
analysis of this clone determined that the splice junctionwere cloned and sequenced. Singly spliced transcripts
were identified and found to contain exon 1 joined to either contained a direct repeat with no conserved splice donor
or splice acceptor sites. This clone probably representsexon 5a or 5b. Exons 5a and 5b differ only in the location
of the splice acceptor; exon 5a uses a splice acceptor at a transcript from a deleted provirus. It is likely that ORF
C is translated from the full-length genomic RNA.position 10,290 (SA7) and exon 5b at position 10,325 (SA8).
These singly spliced transcripts use the predicted ORF B In summary, we have identified nine different mRNAs
from developing and regressing walleye dermal sarco-initiator AUG at nucleotide position 10,570 to encode a
full-length ORF B product (Fig. 2). Another cDNA clone mas. The location of the exons and the splicing patterns
of these transcripts indicate that WDSV undergoes com-(ORF B-3) that contained exon 1 joined to exon 5a was
identified. This clone contains a deletion in exon 5a (from plex splicing similar to that seen in HTLV/BLV, lentivi-
ruses, and spumaviruses (Arrigo et al., 1990; Ciminale etposition 10,730 to position 11,377); however, the reading
frame of ORF B is maintained (Fig. 2). al., 1992; Davis et al., 1987; Muesing et al., 1985; Muranyi
and Flugel, 1991; Renshaw and Casey, 1994; Schwartz etThe differential use of splice sites that occurs in the
generation of WDSV subgenomic transcripts is similar to al., 1990; Viglianti et al., 1990). While a similar expression
pattern of subgenomic transcripts occurs in developingmechanisms described for mRNAs in HIV and SIV. Stud-
ies by Furtado et al. (1991) and Purcell and Martin (1993) and regressing tumors, clearly, quantitative differences
in the level of these transcripts are apparent. The role ofdescribed the presence of four singly spliced mRNAs
that utilize different splice acceptors to generate env tran- accessory proteins as well as the biological significance
of the differential expression of subgenomic transcriptsscripts. Furtado et al. (1991) further demonstrated the
ability of these transcripts to produce gp160/120 and Vpu in developing and regressing tumors will be central in
understanding this unique tumor model.by in vitro transcription and translation experiments. Two
splice acceptors located 15 and 9 nucleotides upstream
of the rev AUG in HIV are both used to generate the first ACKNOWLEDGMENTS
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